Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
64.11B | 57.09B | 51.41B | 50.59B | 44.79B | Gross Profit |
64.11B | 49.96B | 43.97B | 43.33B | 39.06B | EBIT |
6.22B | 0.00 | -1.47B | 716.00M | 5.89B | EBITDA |
0.00 | 703.00M | -807.00M | 7.57B | 7.59B | Net Income Common Stockholders |
4.67B | -188.00M | -1.36B | 5.16B | 5.58B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
704.00M | 722.00M | 736.00M | 763.00M | 311.00M | Total Assets |
111.62B | 103.36B | 97.99B | 99.44B | 125.99B | Total Debt |
7.49B | 7.59B | 7.21B | 7.98B | 7.83B | Net Debt |
6.78B | 6.87B | 6.48B | 7.21B | 7.51B | Total Liabilities |
90.25B | 85.73B | 80.63B | 74.31B | 95.77B | Stockholders Equity |
21.44B | 17.77B | 17.49B | 25.18B | 30.22B |
Cash Flow | Free Cash Flow | |||
8.72B | 3.96B | 4.70B | 4.77B | 5.18B | Operating Cash Flow |
8.93B | 4.23B | 5.12B | 5.12B | 5.49B | Investing Cash Flow |
-8.25B | -3.00B | -1.73B | 510.00M | -3.44B | Financing Cash Flow |
-697.00M | -1.24B | -3.42B | -5.24B | -2.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $163.30B | 19.34 | 36.98% | 1.85% | 20.74% | 51.73% | |
78 Outperform | $114.43B | 12.58 | 15.01% | 1.61% | 11.78% | 4.39% | |
77 Outperform | $20.70B | 9.10 | 17.61% | 2.50% | 13.22% | 24.83% | |
76 Outperform | $26.10B | 15.80 | 22.16% | 0.47% | 12.32% | 29.21% | |
72 Outperform | $51.59B | 11.46 | 23.80% | 1.93% | 12.28% | ― | |
71 Outperform | $57.97B | 13.93 | 16.05% | 1.64% | 9.60% | 36.89% | |
63 Neutral | $12.00B | 9.27 | 8.14% | 79.61% | 12.85% | -5.12% |
In March 2025, Allstate released its monthly report detailing estimated catastrophe losses and policies in force, which is available on their investor website. This announcement provides insights into the company’s financial health and operational impacts, potentially affecting stakeholders’ perspectives on Allstate’s market positioning.
Spark’s Take on ALL Stock
According to Spark, TipRanks’ AI Analyst, ALL is a Outperform.
Allstate’s overall stock score reflects strong financial performance and positive earnings call outcomes, indicating solid growth and effective strategic moves. However, technical analysis suggests weak momentum, and valuation metrics, while favorable, do not significantly enhance the overall attractiveness. Challenges such as wildfire losses and auto insurance growth issues present risks.
To see Spark’s full report on ALL stock, click here.
On January 30, 2025, Allstate Corporation announced a definitive Equity Purchase Agreement with Nationwide Life Insurance Company to sell its group health business, including Direct General Life Insurance Company, NSM Sales Corporation, and The Association Benefits Solution, LLC, for $1.25 billion in cash. This transaction is subject to regulatory approvals and standard closing conditions, potentially impacting Allstate’s operational focus and market positioning by divesting its group health segment.